MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Bovie swings to 2011 black | Earnings Roundup

Bovie swings to 2011 black | Earnings Roundup

By

MassDevice.com Earnings Roundup

Bovie Medical swings to 2011 black
Bovie Medical (NYSE:BVX) posted losses of $876,000, or 5¢ per share, on sales of $6.2 million during the 3 months ended Dec. 31, 2011. That compares with losses of $1.4 million, or 8¢ per share, on sales of $6.2 million during the same period in 2010.

For the full year, Bovie reported profits of $109 million, or 1¢ per share, on sales of $25.4 million. That compares with losses of $1.5 million, or 9¢ per share, on sales of $24.2 million during 2010.
Read more

Cambridge Heart’s losses widen in Q4, 2011
Cambridge Heart (NSDQ:CAMH) posted losses of $1.4 million, or 1¢ per share, on sales of $557,000 during the 3 months ended Dec. 31, 2011. That compares with losses of $1.2 million, or 2¢ per share, on sales of $714,000 during the same period in 2010.

For the full year, Cambridge Heart reported losses of $5.4 million, or 5¢ per share, on sales of $2.2 million. That compares with losses of $5.2 million, or 7¢ per share, on sales of $2.8 million during 2010.
Read more

Daxor moves to 2011 red
Daxor (NYSE:DXR) posted losses of $7.2 million, or $1.70 per share, on sales of $1.4 million during the 12 months ended Dec. 31, 2011. That compares with profits of $5.0 million, or $1.17 per share, on sales of $1.6 million during 2010.
Read more

Dehaier’s Q4, 2011 profits slide
Dehaier Medical Systems (NSDQ:DHRM) posted profits of $99,000, or -1¢ per share, on sales of $5.4 million during the 3 months ended Dec. 31, 2011. That compares with profits of $1.8 million, or 32¢ per share, on sales of $6.7 million during the same period in 2010.

For the full year, Dehaier reported profits of $4.2 million, or 69¢ per share, on sales of $21.6 million. That compares with profits of $5.2 million, or $1.09 per share, on sales of $19.6 million during 2010.
Read more

Losses soar for Derma Sciences
Derma Sciences (NSDQ:DSCI) posted losses of $2.5 million, or 23¢ per share, on sales of $16.5 million during the 3 months ended Dec. 31, 2011. That compares with losses of $347,000 million, or 5¢ per share, on sales of $15.3 million during the same period in 2010.

For the full year, Derma Sciences reported losses of $4.3 million, or 49¢ per share, on sales of $62.6 million. That compares with losses of $2.4 million, or 39¢ per share, on sales of $56.5 million during 2010.
Read more

Echo Therapeutics’s 2011 losses rise
Echo Therapeutics (NSDQ:ECTE) posted losses of $16.7 million, or 49¢ per share during the 3 months ended Dec. 31, 2011. That compares with losses of $4.3 million, or 15¢ per share, during the same period in 2010.
Read more

EDAP narrows Q4, 2011 losses
EDAP (NSDQ:EDAP) posted losses of $779,000, or 6¢ per share, on sales of $10.1 million during the 3 months ended Dec. 31, 2011. That compares with losses of $9.7 million, or 74¢ per share, on sales of $10.8 million during the same period in 2010.

For the full year, EDAP reported losses of $1.3 million, or $1.10 per share, on sales of $31.2 million. That compares with losses of $16.8 million, or $1.29 per share, on sales of $30.6 million during 2010.
Read more

Sales slide, losses soar for Guided Therapeutics
Guided Therapeutics (OTC:GTHP) posted losses of $2.8 million, or 5¢ per share, on sales of $921,000 during the 3 months ended Dec. 31, 2011. That compares with losses of $280,000, or 1¢ per share, on sales of $1.1 million during the same period in 2010.

For the full year, Guided Therapeutics reported losses of $6.6 million, or 14¢ per share, on sales of $3.6 million. That compares with losses of $4.5 million, or 12¢ per share, on sales of $3.4 million during 2010.
Read more

Kips Bay Medical pares 2011 losses
Kips Bay Medical (NSDQ:KIPS) posted losses of $1.1 million, or 7¢ per share, on sales of $94,000 during the 3 months ended Dec. 31, 2011. That compares with losses of $803,000, or 6¢ per share, on sales of $116,000 during the same period in 2010.

For the full year, Kips Bay reported losses of $4.3 million, or 27¢ per share, on sales of $252,000. That compares with losses of $10.9 million, or 81¢ per share, on sales of $223,000 during 2010.
Read more

Profits plunge for Lumenis
Lumenis posted profits of $690,000, or 0¢ per share, on sales of $247.0 million during 2011. That compares with profits of $5.7 million, or 3¢ per share, on sales of $237.7 million during 2010.
Read more

Mazor Robotics boosts sales, pares Q4 losses
Mazor Robotics (PINK:MZRTF) posted losses of $1.3 million, or 6¢ per share, on sales of $1.8 million during the 3 months ended Dec. 31, 2011. That compares with losses of $1.8 million, or 7¢ per share, on sales of $1.3 million during the same period in 2010.

For the full year, Mazor reported losses of $7.8 million, or 36¢ per share, on sales of $5.8 million. That compares with losses of $6.1 million, or 32¢ per share, on sales of $4.2 million during 2010.
Read more

Sales, losses fall for Nephros
Nephros (OTC:NEPH) posted losses of $2.4 million, or 27¢ per share, on sales of $2.2 million during 2011. That compares with losses of $1.9 million, or 93¢ per share, on sales of $2.9 million during 2010.
Read more

Non Invasive Monitoring Systems halves losses, doubles sales
Non Invasive Monitoring Systems (OTC:NIMU) posted losses of $106,000, or 0¢ per share, on sales of $89,000 during 2011. That compares with losses of $311,000, also 0¢ per share, on sales of $187,000 during 2010.
Read more

Patient Safety Technologies slides to 2011 red
Patient Safety Technologies (OTC:PSTX) posted losses of $2.4 million, or 8¢ per share, on sales of $9.5 million during 2011. That compares with profits of $1.8 million, or 6¢ per share, on sales of $14.8 million during 2010.
Read more

Response Biomedical halves 2011 losses
Response Biomedical (TSE:RBM) posted losses of $5.4 million, or 14¢ per share, on sales of $9.0 million during 2011. That compares with losses of $10.1 million, or 32¢ per share, on sales of $6.8 million during 2010.
Read more

Sanuwave cuts losses
Sanuwave Health (OTC:SNWV) posted losses of $10.2 million, or 52¢ per share, on sales of $803,000 during 2011. That compares with losses of $15.2 million, or $1.15 per share, on sales of $728,000 during 2010.
Read more

Losses rise, sales fall for Stereotaxis
Stereotaxis (NSDQ:STXS) posted losses of $32.0 million, or 58¢ per share, on sales of $42.0 million during 2011. That compares with losses of $19.9 million, or 39¢ per share, on sales of $54.1 million during 2010.
Read more

Tengion’s 2011 losses rise
Tengion (NSDQ:TNGN) posted losses of $5.9 million, or 48¢ per share, during the 3 months ended Dec. 31, 2011. That compares with losses of $14.0 million, or 59¢ per share during 2010.

For the full year, Tengion reported losses of $25.6 million, or $3.22 per share, compared with losses of $19.1 million, or 88¢ per share, during 2010.
Read more

Vasomedical’s losses soar
Vasomedical (PINK:VASO) posted losses of $4.3 million, or 4¢ per share, on sales of $16.7 million during 2011. That compares with losses of $1.9 million, or 2¢ per share, on sales of $4.2 million during 2010.
Read more

Sales up, profits down for Young Innovations
Young Innovations (NSDQ:YDNT) posted profits of $16.5 million, or $2.06 per share, on sales of $106.2 million during 2011. That compares with profits of $17.9 million, or $1.87 per share, on sales of $102.8 million during 2010.
Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • How COVID-19 changed medical device clinical trials forever
    The success of remote clinical trial oversight opens the door to hybrid approaches and creates new possibilities for the future of trials. DeviceTalks Because of the pandemic, virtually overnight, all players involved in medical device clinical trials had to pivot to virtual monitoring to keep trials going. What impact did remote trial oversight have on… […]
  • Nuvasive launches ALIF 3D printed porous titanium implant
    Nuvasive this week announced that it has launched its Modulus ALIF 3D printed porous titanium implant for anterior lumbar interbody fusion. San Diego-based Nuvasive designed Modulus for enhanced osseointegration, according to the company. It has a porous surface architecture engineered for fusion and promotes new bone on-growth and in-growth. The design also allows for enhanced… […]
  • Cardinal Health subsidiary faces federal lawsuit over EtO plant in Georgia
    Nearly two dozen people who have lived in the Augusta, Ga. area are suing Cardinal Health subsidiary Kendall Patient Recovery U.S. over ethylene oxide emissions from a medical device sterilization plant in the city. The people suing KPR U.S. in U.S. District Court in Southern Georgia lived and worked within miles of the Augusta facility… […]
  • FDA seeks expanded authority to boost medical device supply chain
    The FDA announced as part of its annual budget proposal that it will include $21.6 million for a new Resilient Supply Chain and Shortages Prevention Program (RSCSPP). Funding from the RSCSPP for the Center for Devices and Radiological Health (CDRH) will provide — the FDA says, for the first time — resources to establish a… […]
  • Using RVI to prevent contamination and maintain purity of pharmaceuticals 
    Here’s how remote visual inspection (RVI) can help pharma companies prevent contamination and maintain product-line purity requirements. Hafees Fraisada, Olympus Bacterial or foreign-particle contamination in production-line equipment can cause serious health issues for consumers and shake public confidence in the industry. Strict purity and contamination control of pharmaceutical manufacturing facilities is required under various international… […]
  • The 18 most innovative medical devices of 2021
    The Galien Foundation today announced the nominees for most innovative medical devices for its 15th annual Prix Galien USA Awards. The foundation nominates devices, biotechnology and pharmaceutical products for its annual Prix Galien awards to highlight products designed to improve the human condition. “The Awards Committee is excited to introduce the nominees for the 2021… […]
  • Stäubli Robotics appoints new pharma and medical device head
    The mechatronics and robotics company Stäubli (Pfäffikon, Switzerland) has named Olivier Cremoux to be the deputy head of pharma and medical device for Stäubli Robotics North America. Cremoux has worked in various Stäubli divisions since 2015 and has served as an international business development manager. In 2018, he began a stint as a North American… […]
  • Novanta acquires ATI Industrial Automation and its surgical robotics tech
    Novanta today announced that it has agreed to acquire ATI Industrial Automation for $172 million in cash. Bedford, Mass.–based Novanta plans to acquire the OEM surgical robotics supplier for $172 million upfront in cash and additional contingent cash payments associated with company financial performance in 2021. The company will also grant performance stock units. ATI… […]
  • Dexcom CEO Kevin Sayer says G7 will be ‘wonderful’
    As we enter what may be the “new normal,” Dexcom’s CEO bets the company can pave the way in continuous glucose monitoring. Dexcom (NSDQ:DXCM), like any company seeking to innovate, remains in a state of perpetual forward motion. That’s the way chair, president & CEO Kevin Sayer views it, anyway. As the company looks toward the… […]
  • How to better clean fiber optics in medical devices
    When it comes to fiber optics in medical devices, cleaning is essential for reliability. Jay Tourigny, MicroCare The use of fiber optics in the medical industry is steadily increasing. As the population continues to grow and age, healthcare providers are using fiber optic devices for better patient diagnosis, monitoring and treatment. Today fiber optics are… […]
  • 7 ways to ensure your medical device product design isn’t biased
    Correcting unintentional biases in medical device product design is a big step toward improving equity in medtech. Achuta Kadambi, an assistant professor at the UCLA Samueli School of Engineering, says when looking at bias in medical devices, there’s often a lot of narrative in the media of what it is. However, it’s also important to… […]

Leave a Reply